OXURION (EBR:OXUR) | WebDisclosure

BRIEF

published on 05/28/2025 at 18:05, 3 days 13 hours ago

Oxurion reçoit des notifications de transparence d'Atlas Special Opportunities II LLC

Industrie Biopharmaceutique Notification De Transparence Titres Avec Droit De Vote Actions Oxurion Atlas Holdings
BRIEF

published on 05/28/2025 at 18:05, 3 days 13 hours ago

Oxurion Receives Transparency Notifications from Atlas Special Opportunities II LLC

Transparency Notification Biopharmaceutical Industry Voting Securities Oxurion Shares Atlas Holdings
PRESS RELEASE

published on 05/28/2025 at 18:00, 3 days 13 hours ago

Oxurion ontvangt transparantiekennisgevingen van Atlas Special Opportunities II LLC
Oxurion NV ontvangt transparantiekennisgevingen van Atlas Special Opportunities II LLC over aandelenbezit volgens Belgische wetgeving. Bedrijf combineert therapeutische innovatie met klinisch onderzoekstechnologieën

Transparantiekennisgevingen Oxurion NV Biofarmaceutisch Bedrijf Belgische Wetgeving Atlas Special Opportunities II LLC
PRESS RELEASE

published on 05/28/2025 at 18:00, 3 days 13 hours ago

Oxurion Receives Transparency Notifications from Atlas Special Opportunities II LLC
Oxurion NV received transparency notifications from Atlas Special Opportunities II, LLC regarding shareholding thresholds pursuant to Belgian Transparency legislation

Oxurion NV Shareholding Thresholds Belgian Transparency Legislation Transparency Notifications Atlas Special Opportunities II LLC
BRIEF

published on 05/22/2025 at 18:05, 9 days 13 hours ago

Résultats de l'Assemblée Générale d'Oxurion

Actionnaires Assemblée Générale Titres Déclarations Prospectives Oxurion
BRIEF

published on 05/22/2025 at 18:05, 9 days 13 hours ago

Results of the Oxurion General Meeting

Securities Shareholders Forward-looking Statements General Assembly Oxurion
PRESS RELEASE

published on 05/22/2025 at 18:00, 9 days 13 hours ago

Oxurion Announces Results on the Annual Shareholders' Meeting of 13 May 2025
Oxurion NV held its annual shareholders' meeting on May 13, 2025, in Leuven, Belgium. Shareholders approved all agenda items. Find more on Oxurion's website

Biopharmaceutical Clinical Data Euronext Brussels Annual Shareholders' Meeting Oxurion NV
PRESS RELEASE

published on 05/22/2025 at 18:00, 9 days 13 hours ago

Oxurion kondigt resultaten aan van de Jaarlijkse Aandeelhoudersvergadering van 13 mei 2025
Oxurion NV hield succesvol zijn jaarlijkse aandeelhoudersvergadering op 13 mei 2025. Alle agenda-items werden goedgekeurd. Meer informatie beschikbaar op www.oxurion.com

Euronext Brussel Oxurion NV Aandeelhoudersvergadering Biofarmaceutisch België
BRIEF

published on 05/20/2025 at 18:05, 11 days 13 hours ago

Oxurion Receives Transparency Notifications from Atlas Special Opportunities II LLC

Actions Transparency Biopharmaceuticals Atlas Special Opportunities Oxurion
BRIEF

published on 05/20/2025 at 18:05, 11 days 13 hours ago

Oxurion reçoit des notifications de transparence d'Atlas Special Opportunities II LLC

Actions Transparence Biopharmaceutique Atlas Special Opportunities Oxurion

Published on 05/31/2025 at 06:16, 1 day 1 hour ago

Moderna Receives U.S. FDA Approval for COVID-19 Vaccine mNEXSPIKE
Published on 05/31/2025 at 03:30, 1 day 4 hours ago

Avant Brands Inc. Announces Voting Results From 2025 Annual General Meeting of Shareholders
Published on 05/31/2025 at 01:45, 1 day 6 hours ago

GLG Life Tech Corporation Reports 2025 First Quarter Financial Results
Published on 05/30/2025 at 23:10, 1 day 8 hours ago

CORRECTION: Nextech3D.ai Migrates MAP Dynamics to AWS, Enabling Scalable AI Architecture and Accelerated Deployment
Published on 05/30/2025 at 23:00, 1 day 8 hours ago

Battery X Metals Achieves Full Capacity Recovery on a Real-World Imbalanced Battery from the #2 Out-of-Warranty Electric Vehicle Model in the United States in Preliminary Trial

View all ACCESSWIRE

Published on 05/31/2025 at 21:00, 10 hours 56 minutes ago

Leclanché annonce le dépôt d'une demande de prolongation du délai de publication du rapport annuel 2024 et la suspension temporaire de la cotation de ses actions nominatives à la SIX Swiss Exchange
Published on 05/31/2025 at 21:00, 10 hours 56 minutes ago

Leclanché SA: Leclanché announces filing of request to extend the publication deadline for the 2024 Annual Report and the temporary suspension of trading of its registered shares on SIX Swiss Exchange
Published on 05/31/2025 at 18:37, 13 hours 18 minutes ago

Meyer Burger files for insolvency for German subsidiaries
Published on 05/31/2025 at 14:50, 17 hours 5 minutes ago

Turkiye Garanti Bankasi A.S.: Brokerage Houses Warrants Redemption Prices
Published on 05/31/2025 at 14:46, 17 hours 9 minutes ago

Turkiye Garanti Bankasi A.S.: CMB Approval for Bond Issuance to Foreign Markets

View all EQS

Published on 05/30/2025 at 22:00, 1 day 9 hours ago

Information sur les comptes annuels
Published on 05/30/2025 at 22:00, 1 day 9 hours ago

Information on the Annual Financial Statements
Published on 05/30/2025 at 18:14, 1 day 13 hours ago

Emova Group - Rapport annuel de Durabilité 23/24
Published on 05/28/2025 at 23:00, 3 days 8 hours ago

Standstill Commitments to hold shares of the company
Published on 05/28/2025 at 23:00, 3 days 8 hours ago

Engagements collectifs de conservation de titres de la société

View all LES ECHOS COMFI WIRE

News